Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
QLIFE Aktie jetzt für 0€ handeln | |||||
05.06. | Qlife Holding AB receives observation status | 115 | GlobeNewswire | Today, June 5, 2025, Qlife Holding AB (the "Company") issued a press release with information that it has entered into a letter of intent for a reverse takeover of Hipro Biotechnology Co., Ltd.,... ► Artikel lesen | |
05.06. | QLife Holding AB: Qlife enters letter of intent with Hipro Biotechnology Co., Ltd. to join forces through a reverse takeover | 78 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") has entered into a non-binding letter of intent ("Letter of Intent") with Hipro Biotechnology Co., Ltd., registration no. 91130100794182204D, ("Hipro") regarding... ► Artikel lesen | |
28.05. | QLife Holding AB: Bulletin from the annual general meeting 2025 of Qlife Holding AB | 66 | GlobeNewswire (Europe) | Qlife Holding AB held its annual general meeting on 28 May 2025. At the meeting, the following resolutions were made.
The English text is an unofficial translation. In case of any discrepancies between... ► Artikel lesen | |
20.05. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q1, January to March 2025 | 92 | GlobeNewswire (Europe) | Progress on all levels
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - first quarter 2025
Revenue in the... ► Artikel lesen | |
07.05. | Qlife Holding AB publishes Annual Report for 2024 | 1 | Cision News | ||
10.04. | QLIFE HOLDING AB: Qlife announces strategic roadmap update | 2 | Cision News | ||
25.03. | QLife Holding AB: Qlife announces that it has received approval from UK authorities to initiate a clinical trial in the UK | 144 | GlobeNewswire (Europe) | The Egoo Phe System, developed to measure phenylalanine (Phe) levels associated with the PKU condition, is now entering its final phase ahead of initial registration in the UK and submission to a Notified... ► Artikel lesen | |
21.03. | QLife Holding AB: Bulletin from the extraordinary general meeting in Qlife Holding AB on 21 March 2025 | 187 | GlobeNewswire (Europe) | Today, on 21 March 2025, an extraordinary general meeting was held in Qlife Holding AB. A summary of the adopted resolutions follows below.
Election and remuneration of the board of directors
The... ► Artikel lesen | |
14.03. | QLIFE HOLDING AB: Qlife announces the last day of trading in BTA | 1 | Cision News | ||
05.03. | QLIFE HOLDING AB: Qlife carries out a directed issue to guarantors in connection with the completed rights issue and a directed issue of warrants to JEQ Capital AB | 1 | Cision News | ||
04.03. | Notice of Extraordinary General Meeting 2025 in Qlife Holding AB | 2 | Cision News | ||
04.03. | QLIFE HOLDING AB: Qlife reaffirms its strategy and plans to expand the Board with three new members | 2 | Cision News | ||
04.03. | The observation status for Qlife Holding AB is removed | 168 | GlobeNewswire | On February 13, 2024, Qlife Holding AB (the "Company") was given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On February 26... ► Artikel lesen | |
26.02. | QLife Holding AB: Qlife announces outcome in rights issue | 156 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
21.02. | QLIFE HOLDING AB: The subscription period in Qlife's rights issue ends on Tuesday, 25 February 2025 | 1 | Cision News | ||
21.02. | QLIFE HOLDING AB: Qlife has successfully verified the biomarkers related to the previously announced LOI | 1 | Cision News | ||
17.02. | QLife Holding AB: Qlife announces the launch of Egoo.AI and the start of sales for the Women's Health platform | 160 | GlobeNewswire (Europe) | Qlife is proud to announce a major expansion of Egoo.Health with the launch of Egoo.AI, an advanced AI-driven platform designed to provide users with personalized insights based on biomarker test results... ► Artikel lesen | |
14.02. | QLIFE HOLDING AB: Qlife launches Thyroid Disease and Vitamin D biomarkers, now available for immediate sales | 1 | Cision News | ||
10.02. | QLIFE HOLDING AB: Qlife publishes information memorandum due to upcoming rights issue | 1 | Cision News | ||
06.02. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q4, October to December 2024 | 149 | GlobeNewswire (Europe) | Transition to a commercial business
Financial summary - fourth quarter 2024
Revenue in the period amounted to kSEK 50 (30).
EBITDA for the period amounted to kSEK -7,721 (-86,903), and net loss... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 47,420 | +1,07 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen auf "Buy" mit einem Kursziel von 60 Euro belassen. Julien Dormois fasste in einer am Donnerstag... ► Artikel lesen | |
FRESENIUS | 42,280 | -0,84 % | Aktienmarkt: Fresenius SE & Co. KGaA-Aktie kann sich nicht behaupten (42,16 €) | Der Anteilsschein von Fresenius SE & Co. KGaA notiert am Mittwoch leichter. Die Aktie kostete zuletzt 42,16 Euro. Für Inhaber von Fresenius+Co KgaA ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 48,320 | -0,98 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 58,18 | +2,76 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
GERRESHEIMER | 48,740 | +0,99 % | Gerresheimer-Aktie: Bleibt die Übernahmefantasie? | Die Gerresheimer-Aktie musste zuletzt heftige Kursverluste hinnehmen. Am Donnerstag verbessert sie sich leicht und steht aktuell bei 47,30 €. Die Ursache für die hohen Kursschwankungen waren Nachrichten... ► Artikel lesen | |
CARL ZEISS MEDITEC | 56,60 | +0,27 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Carl Zeiss Meditec auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen... ► Artikel lesen | |
CAPSOVISION | 3,500 | 0,00 % | CapsoVision Prices IPO Of 5.50 Mln Shares At $5.00/shr | WASHINGTON (dpa-AFX) - CapsoVision Inc. (CV), a commercial-stage medical technology company that develops
advanced imaging and artificial intelligence technologies that are deployed in its... ► Artikel lesen | |
UNITEDHEALTH | 260,90 | -5,66 % | United-Health-Konkurrent: Kaufchance? Diese Aktie ist einfach viel zu billig! | © Foto: Google GeminiDie Aktie des US-Krankenversicherers Centene ist so günstig wie lange nicht. Das gilt nicht nur für die Aktie, sondern auch die Bewertung des Unternehmens.In der US-Krankenversicherungsbranche... ► Artikel lesen | |
CENTENE | 28,745 | -40,15 % | Centene-Aktie läuft heute schlechter (46,0076 €) | Im Minus liegt aktuell der Anteilsschein von Centene . Die Aktie kostete zuletzt 53,62 US-Dollar. Ein Preisabschlag in Höhe von 43 Cent müssen derzeit die Aktionäre von Centene hinnehmen. Für das Papier... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 22,010 | -1,17 % | BrightSpring Health Leads Companies In Line For Triple-Digit Profit Growth | ||
ALIGNMENT HEALTHCARE | 13,610 | -4,15 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
MIMEDX | 6,230 | -0,24 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2025 Operating and Financial Results | Net Sales of $88 million Grew 4% Year-Over-Year for the First Quarter First Quarter GAAP Net Income and Earnings Per Share were $7 Million and $0.05, Respectively First Quarter Adjusted EBITDA... ► Artikel lesen | |
PHETON | 18,380 | +0,27 % | Pheton Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans | ||
NUTEX HEALTH | 122,29 | -7,36 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
GENEDX | 89,79 | -0,55 % | Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts |